These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18394987)

  • 1. A SNO storm in skeletal muscle.
    Stamler JS; Sun QA; Hess DT
    Cell; 2008 Apr; 133(1):33-5. PubMed ID: 18394987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice.
    Durham WJ; Aracena-Parks P; Long C; Rossi AE; Goonasekera SA; Boncompagni S; Galvan DL; Gilman CP; Baker MR; Shirokova N; Protasi F; Dirksen R; Hamilton SL
    Cell; 2008 Apr; 133(1):53-65. PubMed ID: 18394989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
    Glover L; Heffron JJ; Ohlendieck K
    J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
    Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
    FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
    Lyfenko AD; Goonasekera SA; Dirksen RT
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K; Urwyler A; Zorzato F; Treves S
    J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.
    Avila G
    Cell Calcium; 2005 Feb; 37(2):121-7. PubMed ID: 15589992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping domains and mutations on the skeletal muscle ryanodine receptor channel.
    Hwang JH; Zorzato F; Clarke NF; Treves S
    Trends Mol Med; 2012 Nov; 18(11):644-57. PubMed ID: 23069638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pO2 on the activation of skeletal muscle ryanodine receptors by NO: a cautionary note.
    Cheong E; Tumbev V; Stoyanovsky D; Salama G
    Cell Calcium; 2005 Nov; 38(5):481-8. PubMed ID: 16099502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.
    Steele DS; Duke AM
    Arch Biochem Biophys; 2007 Feb; 458(1):57-64. PubMed ID: 16620769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms for dysfunctions of mutated ryanodine receptor isoforms.
    Ogawa Y
    Biochem Biophys Res Commun; 2008 Apr; 369(1):208-12. PubMed ID: 18067858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the calmodulin-dependent inhibition of the RyR1 calcium release channel upon oxidation of methionines in calmodulin.
    Boschek CB; Jones TE; Smallwood HS; Squier TC; Bigelow DJ
    Biochemistry; 2008 Jan; 47(1):131-42. PubMed ID: 18076146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core myopathies and risk of malignant hyperthermia.
    Klingler W; Rueffert H; Lehmann-Horn F; Girard T; Hopkins PM
    Anesth Analg; 2009 Oct; 109(4):1167-73. PubMed ID: 19762745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ryanodine receptors.
    Ogawa Y
    Crit Rev Biochem Mol Biol; 1994; 29(4):229-74. PubMed ID: 8001396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia.
    Bouchama A; Hussain S
    Lancet; 1998 Nov; 352(9142):1785. PubMed ID: 9848381
    [No Abstract]   [Full Text] [Related]  

  • 20. Unravelling calcium-release channel gating: clues from a 'hot' disease.
    McCarthy TV; Mackrill JJ
    Biochem J; 2004 Jun; 380(Pt 2):e1-3. PubMed ID: 15154833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.